| Name | Title | Contact Details |
|---|
Skiff Medical Center is a Newton, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CGH Medical Center is a progressive acute care facility located in the Rock River Valley region of Northern Illinois. Since opening in 1909, CGH has earned a strong reputation throughout the region and consistently receives high ratings for positive public awareness and patient satisfaction. CGH Medical Center is committed to meeting expanding patient needs and to providing leadership in the field of healthcare. This includes broad scale public education and free to low-cost early detection activities. A major expansion was completed in spring of 2008, which produced important advancements. A new suite of surgical rooms accommodates more advanced procedures. A new Obstetrics Department and Birthing Center offers innovative technology, advanced security and private rooms. These additions, along with a new Critical Care Unit, expanded space for Diagnostic Imaging and physician services and a new helicopter pad, enhance the level and quality of our patient care.
MolecularHealth delivers on the promise of personalized, precision medicine. By using advanced proprietary information technologies to sift through terabytes of genetic and molecular test findings in a fraction of the time needed for current manual analysis, MolecularHealth provides doctors and patients with faster, more accurate insights into the role genes play in the progression and treatment of an individual’s cancer. MolecularHealth’s team of doctors, scientists, IT and business experts—including founders and executives of LION Bioscience, US Oncology and Novartis—works in partnership with some of the world’s leading healthcare and information technology companies, including the University of Texas MD Anderson Cancer Center, SAP AG, and the U.S. Food and Drug Administration (FDA). The company has locations in The Woodlands, Texas, Boston, Mass. and Heidelberg, Germany.
Wayne HealthCare is a Greenville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.